TRPV1 and central nervous system cancer: R(+)-methanandamide (10 μM) was shown to elicit apoptosis via a mechanism bypassing cannabinoid and TRPV1 activation (Hinz et al., 2004; Eichele et al., 2006, 2009) in cervical and lung cancer as well as glioma cells.